TRIB (Trinity Biotech plc) Rasio Nilai Pasar marang Nilai Buku

Trinity Biotech Corp (TRIB) - logo korporat

Trinity Biotech plc (TRIB) develops diagnostic systems for detecting diabetes and infections, competing through a closed ecosystem of equipment and high-cost consumables. The company generates revenue by supplying portable analyzers and reagents to global clinics. Current price action, reaching -0.07, confirms the business's resilience due to its leadership in the glucose testing segment and the optimization of internal costs amid moderate growth.

TRIB - Koefisien Nilai Pasar marang Nilai Buku trinitybiotech.com ing rentang 04.07.2022 - 26.10.2026

Rincian metrik keuangan lan pasar Trinity Biotech plc (TRIB)

- rega lan prakiraan konsensus rega:
Rega saham trinitybiotech.com|TRIB - Bagan rega target
- data kapitalisasi pasar:
Nilai pasar Trinity Biotech Corp|TRIB - Rega Nyata Tumbas Perusahaan Kanthi Wutuh
- data kapitalisasi buku:
Nilai Buku saben Saham Trinity Biotech|TRIB - Ekuitas Perusahaan|Rasio Kapitalisasi Pasar marang Nilai Buku trinitybiotech.com|TRIB - Total Aset Bisnis
- data utang lan likuiditas:
Total Utang marang Modal Trinity Biotech plc|TRIB - Utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas trinitybiotech.com|TRIB - Utang agregat perusahaan|Utang-utang marang kapitalisasi buku Trinity Biotech Corp
Analisis wiwitan perusahaan:Trinity Biotech PLC - TRIB
Barang unggulan trinitybiotech.com

Trinity Biotech plc (TRIB) provides critical HIV and diabetes diagnostics through a global network of laboratories. This price-to-book ratio measures the market price premium over net assets. The metric captures the business's fundamental foundation, filtering out short-term speculative fluctuations. For the defensive healthcare sector, the chart's stable trajectory confirms capitalization resilience. Investors should view this indicator as a measure of price strength during periods of market volatility.

Pesaing langsung

Agilent Technologies (A) - Rasio Kapitalisasi Pasar marang Nilai Buku|DGX (questdiagnostics.com) - Rasio Nilai Pasar marang Nilai Buku|Rasio Nilai Pasar marang Nilai Buku ILMN|Rasio Kapitalisasi marang Aset Bersih Exact Sciences Corp|PerkinElmer - Rasio Kapitalisasi Pasar marang Nilai Buku|Koefisien Nilai Pasar marang Nilai Buku Bio-Rad Corp (BIO)|NNNN - Rasio Kapitalisasi Pasar marang Nilai Buku|Rasio Kapitalisasi marang Nilai Buku soterahealth.com SHC|QuidelOrtho Corporation - Rasio Kapitalisasi Pasar marang Nilai Buku|OPK: Rasio Kapitalisasi Pasar marang Nilai Buku|Rasio Nilai Pasar marang Nilai Buku CareDx|Maravai (MRVI) - Rasio Kapitalisasi marang Nilai Buku|FLGT (Fulgent Genetics, Inc.) - Rasio Kapitalisasi Pasar marang Nilai Buku|Rasio Kapitalisasi Pasar marang Nilai Buku LAB|Rasio Nilai Pasar marang Nilai Buku Cytek Biosciences (CTKB)|Rasio Nilai Pasar marang Nilai Buku OraSure Technologies, Inc. OSUR|XGN: Rasio Kapitalisasi marang Aset Bersih|MDxHealth, Inc. - Koefisien Nilai Pasar marang Nilai Buku|Rasio Nilai Pasar marang Nilai Buku LUCD (Lucid Diagnostics Inc.)|PRE - Kapitalisasi Pasar marang Nilai Buku|imdxinc.com - Rasio Kapitalisasi Pasar marang Nilai Buku|PRPH (ProPhase Labs Inc) - Kapitalisasi Pasar marang Nilai Buku|AIMD: Rasio Nilai Pasar marang Nilai Buku|Kapitalisasi Pasar marang Nilai Buku CoDx (CODX)|Rasio Kapitalisasi marang Aset Bersih Heart Test Laboratories|Multiplikator Kapitalisasi Pasar marang Nilai Buku BMRA (biomerica.com)|Rasio Nilai Pasar marang Nilai Buku Cardio Diagnostics Holdings|Nilai Pasar marang Nilai Buku Virax Biolabs Group Limited VRAX|Rasio Kapitalisasi Pasar marang Nilai Buku BJDX (Bluejay)|AWH: Kapitalisasi Pasar marang Nilai Buku|Rasio Nilai Pasar marang Nilai Buku Accelerate Diagnostics|CENTOGENE (CNTG) - Rasio Kapitalisasi marang Nilai Buku|ENZ: Rasio Kapitalisasi Pasar marang Nilai Buku|Kapitalisasi Pasar marang Nilai Buku Fresh2 (FRES)|Rasio Kapitalisasi marang Aset Bersih Genetic Technologies|Multiplikator Kapitalisasi Pasar marang Nilai Buku 23andMe Inc ME|PMD: Rasio Kapitalisasi marang Aset Bersih